Bird flu scares consumers; Drug company curtails sales of antiviral remedy
Sometimes good business isn’t a good thing for the business itself. Roche, the Switzerland-based pharmaceutical company, is finding itself in the odd position of refusing to sell its product to its customers. A bit of a backdrop: as the threat of bird-flu grew, and the introduction of the antiviral... Sign in to see full entry.